Bleeding clinical trials in Florida
8 studies for Bleeding are looking for participants at sites in Florida.
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Nouvelle Clinical Research LLC, Cutler Bay
- South Florida Research Organization LLC, Medley
- Inpatient Research Clinic LLC, Miami Lakes
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07175428REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- Bioresearch Partner- Hialeah Hospital, Hialeah
- Helios Clinical Research, North Miami Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07410117Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Excel Medical Clinical Trials, dba Flourish Research, Boca Raton
- Nouvelle Clinical Research LLC, Cutler Bay
- Nature Coast Clinical Research - Inverness, Inverness
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07626411CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
- University of Miami, Miami
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Oct 30, 2026 · NCT05958342Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 7, 2026 · NCT05568719Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
- Miami VA Healthcare System, Miami, FL, Miami
RecruitingPhase 4
Ages 22 and older · All sexes · Updated Sep 23, 2026 · NCT06953726Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- University of Florida -UF Health, Gainesville
- Johns Hopkins All Children's, St. Petersburg
RecruitingPhase 2/3
Up to age 17 · All sexes · Updated Jun 8, 2026 · NCT04924322Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
- University of Florida Jacksonville, Jacksonville
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Feb 5, 2026 · NCT06691191From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.